TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Publisher DOI
PubMed ID
24978903
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition, strongly associated with the metabolic syndrome, that can lead to progressive hepatic fibrosis, cirrhosis and hepatic failure. Subtle inter-patient genetic variation and environmental factors combine to determine variation in disease progression. A common non-synonymous polymorphism in TM6SF2 (rs58542926 c.449 C>T, p.Glu167Lys) was recently associated with increased hepatic triglyceride content, but whether this variant promotes clinically relevant hepatic fibrosis is unknown. Here we confirm that TM6SF2 minor allele carriage is associated with NAFLD and is causally related to a previously reported chromosome 19 GWAS signal that was ascribed to the gene NCAN. Furthermore, using two histologically characterized cohorts encompassing steatosis, steatohepatitis, fibrosis and cirrhosis (combined n=1,074), we demonstrate a new association, independent of potential confounding factors (age, BMI, type 2 diabetes mellitus and PNPLA3 rs738409 genotype), with advanced hepatic fibrosis/cirrhosis. These findings establish new and important clinical relevance to TM6SF2 in NAFLD.
Date Issued
2014
Publication Type
Article
Subject(s)
Language(s)
en
Author(s)
Liu, Yang-Lin | |
Reeves, Helen L | |
Burt, Alastair D | |
Tiniakos, Dina | |
McPherson, Stuart | |
Leathart, Julian B S | |
Allison, Michael E D | |
Alexander, Graeme J | |
Anty, Rodolphe | |
Donaldson, Peter | |
Aithal, Guruprasad P | |
Francque, Sven | |
Van Gaal, Luc | |
Clement, Karine | |
Ratziu, Vlad | |
Day, Christopher P | |
Daly, Ann K | |
Anstee, Quentin M |
Journal
Nature communications
Publisher
Nature Publishing Group
ISSN
2041-1723
Access(Rights)
open.access